Ana Martínez
Marketing Director
Panreac Quimica S.L.U.
About me
Specialist in business development, more focus in plasma derivatives and biopharmaceutical applications.
Exhibitor Access Type
Exhibitor - Online only
Country
Spain
Organization Type
Manufacturer/Innovator
Business Activity
Excipients ManufacturerFine Chemicals Company
Markets Active In
East Asia (e.g., China, Japan, Korea)Europe - EU countriesOceania
Geographical areas your company plans to expand into
North America (e.g., USA, Canada)Oceania
Registration Type
Exhibitor
About me (Individual)
Department
Sales
Job Function
Manager without StaffSales Manager
Purchasing Responsibility
I have no purchasing responsibility
Offering/Interested In
Interested in: Department
Purchasing/ Procurement/ Sourcing
Interested in: Company Type
Manufacturer/Innovator
Interested In: Company Certification
GMPISO
Interested In: Product Certification
CEFDANone
Interested In
Interested In: Products & Service Category
BiopharmaceuticalsPharmaceutical Products/ATC Coding
Interested In: Biopharmaceuticals
Biopharmaceuticals (general category)DownstreamUpstream
Interested in: Pharmaceutical products / ATC coding
Antineoplastics and immunomodulating agentsBlood and blood forming organsSystemic Hormonal preparations, excl. sex hormonesVariousVeterinary Pharmaceuticals
Interested In (ATC Coding)
Interested In: Antineoplastics and Immunomodulating Agents
ImmunostimulantsImmunosuppressants
Interested In: Blood and Blood Forming Organs
Blood substitutes and perfusion solutions
Interested In: Systemic Hormonal Preparations
Pituitary and Hypothalamic hormones and analoguesThyroid Therapy
Interested In: Various
Diagnostic agentsGeneral NutrientsOrphan
Contact details
Is member of
Panreac Quimica
Panreac Applichem
Exhibitors
Panreac Quimica S.L.U.
Exhibitors
Panreac Quimica S.L.U.
Exhibitorsis attending
Global Pharma Manufacturing in Flux: Adapting to a New Era of Complexity
Tuesday, October 28, 2025 10:00 AM to 10:30 AM
Hall 4.1 - 4.1L8
CDMOs at a Crossroads: Scaling, Adapting, and Partnering for the Future
Tuesday, October 28, 2025 10:35 AM to 11:20 AM
Hall 4.1 - 4.1L8
Raman Sehgal · Molecule to Market
Nuria Amador · Almirall
Gil Roth · Pharma & Biopharma Outsourcing Association
Anil Kane · Thermo Fisher Scientific
Current Status of Pharma and Biotech From a Capital Markets Perspective and the Implications for Pharma Services
Thursday, October 30, 2025 10:00 AM to 10:30 AM
Hall 4.1 - 4.1L8
Thomas Kern · ISP HEALTHCARE
Off-Patent Semaglutide in 2026: The Next Revolution in Anti-Obesity Medications
Tuesday, October 28, 2025 12:15 PM to 12:40 PM
Hall 4.1 - 4.1J48
Aurelio Arias · IQVIA
Panel: Advancing ADCs: Precision Innovation for the Future of Targeted Therapies
Tuesday, October 28, 2025 3:15 PM to 4:00 PM
Hall 4.1 - 4.1J48
Kern Chang · LOTTE BIOLOGICS
Juergen Rotzler · Solvias AG